In the same announcement, Coherus reported that in the process of inspecting three sites in China enrolling patients for two pivotal trials of its PD-1 antibody toripalimab in recurrent nasopharyngeal carcinoma (NPC), the FDA identified one observation
GSH occurring in the sample reacts with 5,5-dithiobis(2-nitrobenzoic acid) (DTNB) to form the mixed disulfide GS-TNB and the chromophore 5-thio-2-nitrobenzoic acid (TNB)
doi: 10.3389/fimmu.2019.01050 Received 16 July 2018 Accepted 24 April 2019 Published 09 May 2019 Volume 10 - 2019 Edited by Robert Murray Hamilton, Hospital for Sick Children, Canada Reviewed by Rui Li, University of Pennsylvania, United States
Recognized by the International Agency for Research on Cancer (IARC) as a probable human carcinogen, NSW is believed to contribute to carcinogenesis primarily through circadian disruption induced by exposure to light at night
Do I need a prescription for peptide therapy in Dallas
Toward hemocompatible self-assembling antimicrobial nanofibers: understanding the synergistic effect of supramolecular structure and PEGylation on hemocompatibility
